PPT Header Options.jpg

International Articles on Ozone Therapy for COVID-19

051720-Italy-SIOOT Oxygen-Ozone Therapy For Covid-19--A Success In 20 Italian Hospitals

071720-TRTK Summary Report - Document Thread

is a consolidation of all the following
reports to facilitate word searchers.


051520-TRTK Informe resumido -
Hilo conductor del documento
es una consolidación de todo lo siguiente
informes para facilitar la búsqueda de palabras

What's New?

09/09/20 Italy to offer free ozone therapy.

08/26/20 Cuba achieves 40% of patients receive negative test swabs in 5 days with rectal delivery of ozone.


”A Novel Approach to Treating COVID-19 Using Nutrition and Oxidative Therapies”

 

  •  Vitamin A: 100,000 IU/day in the form of emulsified Vitamin A palmitate

  • Vitamin C:  1,000 mg/hour while awake in the form of ascorbic acid until bowel tolerance (loose stools) was reached

  • Vitamin D3:  50,000 IU/day in an emulsified form

  • Iodine:  25 mg/day in the form of Lugol’s solution or tableted Lugol’s solution

 

Nebulize a dilute solution of 0.04% hydrogen peroxide in normal saline.  A sterile 250 cc bag of normal saline was injected with 3 cc of 3% food grade hydrogen peroxide and 1 cc of magnesium sulfate.  The patient was instructed to draw of 3 cc of the dilute solution and nebulize it hourly until symptoms improve.  Additionally, the patient was instructed to add in one drop of 5% Lugol’s solution to the dilute hydrogen peroxide mixture.  As symptoms improved the frequency of nebulizing could be reduced by the patient.

 

If symptoms worsened and there was a concern that the patient was suffering from a more severe case, the patient was advised to come to the office and receive intravenous injections of Vitamin C and hydrogen peroxide along with intramuscular injections of ozone.

 

Dosing:

  • Vitamin C:  2.5 grams of sodium ascorbate (5 cc of 500 mg/cc ascorbic acid solution) mixed with an equal amount of sterile water given as an intravenous push over 2-3 minutes

  • Hydrogen peroxide:  30 cc of a 0.03% solution of dilute hydrogen peroxide given as an intravenous push over 2-3 minutes

  • Ozone:  20 cc of 18 mcg/cc ozone (as an oxygen/ozone gas mixture) given in each buttock as an intramuscular injection

Click image for link to video of hearing
Highlights from December 7, 2020
Senate Committee on HHS:


Note: Click here for link to partical transcribed notes from hearing.
Transcribed comments may not be word for word in all instances.


 

Minute Marker 2:49:45
Imelda Garcia, Associate Commissioner, Laboratory and Infectious Disease Services Texas Department of State Health Services, Austin, TX

2:50:45 The Initial supply could be approved in one of two ways. 
It could be fully licensed as a vaccine or more likely it will be licensed for Emergency Use Authorization (EUA).

- Vaccines under an EUA CANNOT BE MANDATED

 

- “IN TEXAS, RECEIVING THE COVID 19 VACCINE IS COMPLETELY VOLUNTARY AND WE WANT TO MAKE SURE EVERYONE KNOWS THAT – BECAUSE IT IS LICENSED UNDER AN EUA – IT CANNOT BE MANDATED BY ANYONE.”

2:51:40:  Two doses from the same manufacturer separated by either 21 or 22 days will be required for the individual
to attain immunity from most of the COVID 19 vaccines.

As of December 14, 2020,
Statements regarding vaccines ability to invoke immunization to prevent COVID 19 infections are inaccurate. 

Senate HHS Dec 7 image.jpg
CDC statment - no available vaccines pre

​1:41:34 – Senator Borris Miles, Can you go into any detail of information at this time about the side effects…yes sir the vaccine side effects”
 

  1. 1:41:53 Larry Schlesinger, Professor/President/CEO(Texas Biomedical Research Institute), San Antonio, TX
    “no I mean, I think the side effects we are most familiar with are local – about 10% to 15% of people, remember these are trials of 30K to 40K people and it’s not the general community – it appears that these vaccines cause at most a local response of swelling and pain in the arm and that we need to educate the community ... I also share concern about people coming back to their second shot if they have had a reaction to the first one.  1:42:28 But with regard to others systemics, some fevers, feeling tired over the first day… this is what we’ve been hearing about and  until the data comes out I would not be able to comment, we certainly don’t know about long lasting effects although the FDA delayed its review until we had 2 months of safety data. 
     

  2. 1:43:05 Once we open this up to hundred of millions, billions of people there will be efficacy in the general public and how durable the response is, how long will it last.  We can almost anticipate that some people will not have a response adequate for protection and some people will have partial response. 

       _________________________________________________________

 

Source: Weston A. Price Foundation
 

Participants in every Covid-19 vaccine trial have reported adverse reactions including high fever, chills, muscle pains and headaches. Some have even reported severe reactions that required hospitalization and invasive treatment.(4-6) 


According to the FDA, potential long-term effects may include Guillain-Barré syndrome, brain swelling, muscle weakness and paralysis, convulsions and seizures, stroke, narcolepsy, shock, heart attack, autoimmune disease, arthritis and joint pain, multisystem inflammatory syndrome in children, and death.(7) Some UK health workers have experienced anaphylactic shock after receiving one dose of the approved vaccine.(8)

 

4.  Jackson LA, Anderson EJ, Rouphael NG et al. An mRNA vaccine against SARS-CoV-2 – preliminary report. New England Journal of Medicine. 2020;383(20):1920-1931. https://www.nejm.org/doi/full/10.1056/NEJMoa2022483.

5.  Allen A, Szabo L. NIH “very concerned” about serious side effect in coronavirus vaccine trial. Scientific American, September 15, 2020. https://www.scientificamerican.com/article/nih-very-concerned-about-serious-side-effect-in-coronavirus-vaccine-trial/.

6.  Mayer A. Leading COVID vaccine candidates plagued by safety concerns. The Defender, November 13, 2020. https://childrenshealthdefense.org/defender/covid-vaccine-candidates-safety-concerns/?itm_term=home. .

7.  U.S. Food and Drug Administration. Vaccines and Related Biological Products Advisory Committee, October 22, 2020 Meeting Presentation, slide #16. https://www.greenmedinfo.com/blog/covid-19-vaccine-bombshell-fda-documents-reveal-death-21-serious-conditions-possi1.

8.  Reals T. U.K. warns against giving Pfizer vaccine to people prone to severe allergic reactions. CBS News, December 9, 2020. https://www.cbsnews.com/amp/news/covid-vaccine-pfizer-shot-uk-warning-people-with-history-of-significant-allergic-reactions/#app.
 

Source: NY Times

 

Alaska Health Workers Got Emergency Treatment After Receiving Pfizer’s Vaccine -

Below December 15, 2020 screen shot from CDC FAQ page - removed December 17, 2020.
Pfizer-90.png

Vaccine manufacturers claim that Covid-19 vaccines are 95 percent “effective,” but the FDA is allowing companies to define effectiveness as “prevention of mild symptoms. " The studies are not designed to detect a reduction in outcomes such as severe illness, hospitalization or death."

October 21, 2020 thebmj.org 

An FDA Pfizer briefing paper published December 10, 2020 revealed 43 percent more suspected cases of Covid-19 in the vaccinated group than in the placebo group within seven days of vaccination.

https://www.fda.gov/media/144245/download, page 42.

DSHS 2020-2019 comparative of influenza

2:19:15 Dr Matt Leveno Medical Director Parkland MICU and COVID TCU (UT Southwestern) 

 

Q:  What type of volume are we seeing with influenza?

A:  Zero hospitalizations as of right now. 

2:35:35 James J. McCarthy Chief Physician Executive (Memorial Hermann Health System) Houston, TX

Q: Senator Kolkhorst - What are you seeing in influenza rates:

A: Exceptionally little not aware of any influenza – later confirms -  
6 admissions for flu in October

Following charts of Influenza-like-illnesses by
Texas DSHS from 2015 - 2020

 

June 12, 2020 Texas Medical Board (TMB) Clarifies Access To
Ozone Therapy for the Treatment of COVID-19
under
Texas Administrative Code Title 22 Part 9 Chapter 200 - STANDARDS FOR PHYSICIANS PRACTICING COMPLEMENTARY AND ALTERNATIVE MEDICINE (CAM)

 

July 31, 2020 - TMB Press Release TMB clarifies any therapy is available under CAM rules since there is no established "standard of care" approved by the FDA.

Excerpts:  “Both patients and physicians have a right to decide what treatment may be used for COVID-19. The Board does not issue endorsements of the use of any specific drugs or treatments for COVID-19, but any treatment decision must be made with full, proper and accurate disclosure by a physician.
Physicians should refer to laws and Board rules, including those for complementary and alternative medicine, when considering potential treatments and medical decisions regarding COVID-19.”



View TMB video   |  View April 2nd and June 23rd  TRTK Press Releases

Yes, there are treatment options for COVID being successfully used in Italy, China, Spain and many other countries as reported in news articles and medical publications. 

 

Many therapy success stories have been shared by physicians on social media that we’ve all seen talking about success using:
 

  1. Hydroxychloroquine the malaria drug
              - (Ivette Lozano, MD - Dallas), 

  2. Budesonide inhalant steroids
              - (Richard Bartlett, MD - Midland - case study, protocol)

  3. Ivermectin​ - Science Direct

  4. Natural substances like:
             - Vitamins A, C, D, iodine, hydrogen peroxide, ozone
               (David Brownstein, MD - West Bloomfield, MI),
             - Melatonin -PubMed,
             - Cannabidiol - PubMed, 
             - Iodine (Edward Group, DC - Houston, TX), etc.  
           

See Texas Senator, Bob Hall - District 2, interview several doctors who discuss their success with various adjuvant therapies.  

COVID-19
How can I cure thee? Let me count the ways.
Commentary by Thomas E. Levy, MD, JD


Yes, there are supportive care options for COVID. 

So what's the Problem?


- The Texas Board of Pharmacy put forth emergency board rule §291.30 concerning Medication Limitations on March 20, 2020. 

§291.30.Medication Limitations.

No prescription or medication order for chloroquine, hydroxychloroquine, mefloquine, or azithromycin may be dispensed or distributed unless all the following apply:

(1) the prescription or medication order bears a written diagnosis from the prescriber consistent with the evidence for its use;

(2) the prescription or medication order is limited to no more than a fourteen (14) day supply, unless the patient was previously established on the medication prior to the effective date of this rule; and

(3) no refills may be permitted unless a new prescription or medication order is furnished.

The agency certifies that legal counsel has reviewed the emergency adoption and found it to be within the state agency's legal authority to adopt.

Filed with the Office of the Secretary of State on March 20, 2020.
 

This rule expired July 17, 2020. However, there are reports of  pharmacies still refusing to fill physicians prescriptions related to COVID.

 

So where are the problems?
 

  1. Centers for Disease Control (CDC) -
    Posted November 3rd, checked 12/16/20
    "Remdesivir is the only Food and Drug Administration-approved drug for the treatment of COVID-19. In this section, the COVID-19 Treatment Guidelines Panel (the Panel) provides recommendations for using antiviral drugs to treat COVID-19 based on the available data. As in the management of any disease, treatment decisions ultimately reside with the patient and their health care provider.

    Prior to November 3rd the CDC claimed that there is no treatment 

"There are no drugs or other therapeutics presently approved by the U.S. Food and Drug Administration (FDA) to prevent or treat COVID-19.

Current clinical management includes infection prevention and control measures and supportive care, including supplemental oxygen and mechanical ventilatory support when indicated
." 
(Posted April 25st checked 9/8/20)

 

  1. CDC - Antiviral Drugs That Are Approved or Under Evaluation for the Treatment of COVID-19

         Last Updated: November 3, 2020, checked 2/4/21
 

Remdesivir

See Therapeutic Management of Patients with COVID-19 for recommendations on using remdesivir with or without dexamethasone.

Chloroquine or Hydroxychloroquine With or Without Azithromycin

The Panel recommends against the use of chloroquine or hydroxychloroquine with or without azithromycin for the treatment of COVID-19 in hospitalized patients (AI).
 

In nonhospitalized patients, the Panel recommends against the use of chloroquine or hydroxychloroquine with or without azithromycin for the treatment of COVID-19, except in a clinical trial (AI).
 

The Panel recommends against the use of high-dose chloroquine (600 mg twice daily for 10 days) for the treatment of COVID-19 (AI).
 

Lopinavir/Ritonavir and Other HIV Protease Inhibitors

The Panel recommends against using lopinavir/ritonavir (AI) or other HIV protease inhibitors (AIII) to treat COVID-19, except in a clinical trial.
 

Ivermectin

The Panel recommends against the use of ivermectin for the treatment of COVID-19, except in a clinical trial (AIII).
NOTE:  Ivermectin is being promoted by:
 
Front Line Covid-19 Critical Care Alliance  |  Prophylaxis & Treatment Protocols for Covid-19

  1. National Institute of Health (NIH)-
    Posted of August 27, 2020, checked 12/16/20

     

The COVID-19 Treatment Guidelines Panel (the Panel) recommends against the use of any agents for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pre-exposure prophylaxis (PrEP), except in a clinical trial (AIII).
 

The Panel recommends against the use of any agents for SARS-CoV-2 post-exposure prophylaxis (PEP), except in a clinical trial (AIII).

Note:  The Texas Medical Association (TMA) is supporting this NIH policy.  “The Texas Medical Association, an advocacy group for physicians, recommends against the use of the hydroxychloroquine and azithromycin for the treatment of COVID-19 outside of clinical trials.  It cites the Food and Drug Administration in saying that there are presently no approved treatments for COVID-19.” 
 

  1. Federal Trade Commission (FTC) - Cannot advertise services
    is sending out warning letters to anyone who puts the words, “prevent, treat and COVID” in the same website, even though Texas law is clear that patients have the right to seek  and physicians have the right to provide alternative therapies.  These rights are also supported by the World Medical Association Ethics Principals #37
     

  2. US Department of Justice (DOJ) -  issue injunctions to halt services 

 

Why aren’t government efforts going toward offering out-patient supportive care options instead of tracking people?

The $295 million Texas spent on contact tracking technology would go a long way on giving people supportive care options to keep them out of the hospitals. 

Why don’t we treat this infection and get people well rather than locking down businesses, destroying lives and collapsing world economies?

Yes, there are options for COVID!

Let get well, let’s open our churches, our businesses, our schools and start to rebuild from this tragic pandemic.

Yes, Ozone works to treat COVID-19!
Says clinical trials from China, Italy, Spain and Cuba.

learn more ...

August 26, 2020 Cuba, 

"At this meeting, the results of a clinical trial with the use of ozonetherapy by rectal route in patients confirmed with SARS-CoV-2, who had mild and moderate symptoms, were also presented. As detailed by the Doctor of Science Sarahi Mendoza Castaño, Director of Research, Development and Innovation of the National Center for Scientific Research, it was evidenced that "the association of the ozone therapy with the conventional treatment of the COVID-19 increased by 40% the number of patients with negative PCR test on the fifth day".

May 17, 2020 Italy.  The Scientific Society of Oxygen Ozone Therapy (SIOOT) just release a comparative report stating , "Oxygen ozone therapy is a success for Covid-19 in Italy – 94% of non‐intubated and 73% of intubated patients rapidly recover. By comparison, only 20% of NYC’s intubated patients recover at all.   
 

... In NYC 80% of intubated patients ultimately die [16].  Only 17% of intubated patients on oxygen-­‐ozone therapy died.  Similarly, abc7.com reports that NYC’s intubated patients average 11-­‐21 days to become extubated.  The oxygen-­‐ozone group’s extubates became so in only 5 days on average.  Click here for report.

No information contained on this site is to be interpreted or implied to be providing legal advice  or medical advice for the "prevention, treatment or cure" of any disease or condition. 

No information is to be considered as a substitute for advice from an attorney or a medical professional. 

Statements made regarding use of the terms, "prevent, treat or cure"  or supportive care  are often based upon reports from national and international clinical studies  and may not been evaluated nor approved  by the FDA.

 

Groups referenced on this site are not to be interpreted as their endorsement of all views shared.
 

For more information, email: info@texasrighttoknow.com         Contact Us

Follow Us

  • Facebook Social Icon